Literature DB >> 19886703

Functional divergence of Helicobacter pylori related to early gastric cancer.

Kuvat T Momynaliev1, Sergey V Kashin, Vera V Chelysheva, Oksana V Selezneva, Irina A Demina, Marya V Serebryakova, Dmitry Alexeev, Vladimir A Ivanisenko, Ewgeniya Aman, Vadim M Govorun.   

Abstract

Helicobacter pylori is an extra macro- and microdiverse bacterial species, but where and when diversity arises is not well-understood. To test whether a new environment accelerates H. pylori genetic changes for quick adaptation, we have examined the genetic and phenotypic changes in H. pylori obtained from different locations of the stomach from patients with early gastric cancer (ECG) or chronic gastritis (CG). Macroarray analysis did not detect differences in genetic content among all of the isolates obtained from different locations within the same stomach of patients with EGC or CG. The extent and types of functional diversity of H. pylori isolates were characterized by 2-D difference gel electrophoresis (2D DIGE). Our analysis revealed 32 differentially expressed proteins in H. pylori related to EGC and 14 differentially expressed proteins in H. pylori related to CG. Most of the differentially expressed proteins belong to the antioxidant protein group (SodB, KatA, AphC/TsaA, TrxA, Pfr), tricarbon acid cycle proteins (Idh, FrdA, FrdB, FldA, AcnB) and heat shock proteins (GroEL and ClpB). We conclude that H. pylori protein expression variability is mostly associated with microorganism adaptation to morphologically different parts of the stomach, which has histological features and morphological changes due to pathological processes; gene loss or acquisition is not involved in the adaptation process.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19886703     DOI: 10.1021/pr900586w

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  7 in total

1.  Molecular association of pathogenetic contributors to pre-eclampsia (pre-eclampsia associome).

Authors:  Andrey S Glotov; Evgeny S Tiys; Elena S Vashukova; Vladimir S Pakin; Pavel S Demenkov; Olga V Saik; Timofey V Ivanisenko; Olga N Arzhanova; Elena V Mozgovaya; Marina S Zainulina; Nikolay A Kolchanov; Vladislav S Baranov; Vladimir A Ivanisenko
Journal:  BMC Syst Biol       Date:  2015-04-15

2.  Differential proteomics of Helicobacter pylori associated with autoimmune atrophic gastritis.

Authors:  Ombretta Repetto; Stefania Zanussi; Mariateresa Casarotto; Vincenzo Canzonieri; Paolo De Paoli; Renato Cannizzaro; Valli De Re
Journal:  Mol Med       Date:  2014-02-28       Impact factor: 6.354

3.  ANDSystem: an Associative Network Discovery System for automated literature mining in the field of biology.

Authors:  Vladimir A Ivanisenko; Olga V Saik; Nikita V Ivanisenko; Evgeny S Tiys; Timofey V Ivanisenko; Pavel S Demenkov; Nikolay A Kolchanov
Journal:  BMC Syst Biol       Date:  2015-04-15

4.  Comparative Analysis of Two Helicobacter pylori Strains using Genomics and Mass Spectrometry-Based Proteomics.

Authors:  Roger Karlsson; Kaisa Thorell; Shaghayegh Hosseini; Diarmuid Kenny; Carina Sihlbom; Åsa Sjöling; Anders Karlsson; Intawat Nookaew
Journal:  Front Microbiol       Date:  2016-11-11       Impact factor: 5.640

5.  FunGeneNet: a web tool to estimate enrichment of functional interactions in experimental gene sets.

Authors:  Evgeny S Tiys; Timofey V Ivanisenko; Pavel S Demenkov; Vladimir A Ivanisenko
Journal:  BMC Genomics       Date:  2018-02-09       Impact factor: 3.969

6.  Targeted identification of glycosylated proteins in the gastric pathogen Helicobacter pylori (Hp).

Authors:  Kanokwan Champasa; Scott A Longwell; Aimee M Eldridge; Elizabeth A Stemmler; Danielle H Dube
Journal:  Mol Cell Proteomics       Date:  2013-06-10       Impact factor: 5.911

7.  Proteomics-Based Identification and Analysis of Proteins Associated with Helicobacter pylori in Gastric Cancer.

Authors:  Jianjiang Zhou; Wenling Wang; Yuan Xie; Yan Zhao; Xian Chen; Wenjie Xu; Yan Wang; Zhizhong Guan
Journal:  PLoS One       Date:  2016-01-08       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.